Home › Soft Tissue Sarcoma › North Carolina › Winston-Salem
Soft Tissue Sarcoma clinical trials in Winston-Salem, NC
3 studies for Soft Tissue Sarcoma are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
- Novant Health Forsyth Medical Center, Winston-Salem
- Novant Health Cancer Institute - Kernersville, Kernersville · 10 mi away
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
RecruitingObservational study
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
RecruitingPhase 2
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
About Soft Tissue Sarcoma
Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available
More about Soft Tissue Sarcoma on MedlinePlus
Soft Tissue Sarcoma trials in other cities
- Houston, TX32 studies
- New York City, NY20 studies
- Boston, MA17 studies
- Los Angeles, CA13 studies
- St. Louis, MO12 studies
- Columbus, OH12 studies
- Washington, DC11 studies
- Memphis, TN10 studies
- Philadelphia, PA9 studies
- Aurora, CO8 studies
- Nashville, TN8 studies
- Durham, NC8 studies
Other studies in Winston-Salem
- Acute Myeloid Leukemia20 studies
- Cancer (all types)19 studies
- Multiple Myeloma16 studies
- Breast Cancer15 studies
- Cardiovascular Disease13 studies
- Non-Small Cell Lung Cancer11 studies
- COPD11 studies
- Ovarian Cancer10 studies
- Myeloproliferative Neoplasms9 studies
- Myelofibrosis9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.